Keywords: gsk, asks, south, africa, drop, arv, price

GSK asks South Africa to drop ARV price probe; grants fourth voluntary license

Article | 04 October 2004

Print This

GlaxoSmithKline has asked South Africa's Competition Tribunal to drop an investigation into the prices of its HIV/ AIDS drugs, claiming ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in